William Ward
Adult Health · Opelika, ALNPI 1376106922
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 504 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 44 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. Among adult health clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 504 payments — averaging $19.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- AbbVie$1K
- Novo Nordisk$706
- Lilly USA, LLC$623
- Amgen$597
- Pfizer$512
- plus $5K from 38 others
What the payments were for
- Food & beverage$9,654100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$356
- MINIMED 780G$142
- Repatha$125
- XARELTO$120
- TRELEGY ELLIPTA$112
- ZEPBOUND$111
- AIRSUPRA$106
- BREZTRI$103
How this compares
$9,654 in reported general payments places this provider in the 95th percentile of 308 adult health providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 18 | $18,656 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 21 | $13,805 |
| JanuviaSitagliptin Phosphate | 19 | $13,785 |
| MounjaroTirzepatide | 13 | $13,084 |
| Lagevrio (Eua)Molnupiravir | 18 | $9,253 |
| MyrbetriqMirabegron | 18 | $7,982 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $7,354 |
| Doxycycline Hyclate | 336 | $3,221 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 273 | $3,110 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 64 | $1,703 |
| Oseltamivir Phosphate | 54 | $1,467 |
| Azithromycin | 255 | $1,232 |
| Diclofenac Sodium | 96 | $1,074 |
| Betamethasone Dipropionate | 25 | $1,032 |
| Methylprednisolone | 117 | $891 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia, Lagevrio (Eua) | $105 | $23,03837 claims |
| Novo NordiskOzempic | $706 | $18,65618 claims |
| GSKTrelegy Ellipta | $354 | $13,80521 claims |
| Lilly USA, LLCMounjaro | $623 | $13,08413 claims |
| Astellas Pharma US IncMyrbetriq | $451 | $7,98218 claims |
| AstraZenecaBreztri Aerosphere | $1,618 | $7,35412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 308 adult health providers in Alabama.
Other adult health in Opelika
- Wendy CantrellMountain Brk$276K
- Lanier OhareBirmingham$42K
- Jessica WrightBirmingham$33K
- Sara HopperBirmingham$21K
- Andrea SuttonBirmingham$21K
- Olivia ViseHoover$15K
- Lindsay SmithPelham$14K
- Alaina OdomAlabaster$14K
- Holly CluckMontgomery$12K
- Ashley YorkHoover$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.